Asian man wearing CPAP mask, connecting to air hose, sleeping on his bed in his bedroom with large window, good for sleep apnea story Patients and doctors are disagreeing about sleep apnea ...

But Zepbound is only for people with obesity and sleep apnea, the AASM noted. Also, Zepbound can reduce the severity of sleep apnea through weight loss but might not cure the problem.

Here’s a closer look at GLP-1 drugs like Ozempic, Mounjaro, and Zepbound for sleep apnea, including how obesity is related to sleep apnea and how these medications might help.

In December, GLP-1 agonist tirzepatide (Zepbound) became the first drug approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity after two trials showed it reduced ...

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain ...

Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, ... GLP-1 Zepbound is approved as first drug for sleep apnea. Dec 23, 2024.

Additionally, Zepbound is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. Zepbound should be used with a reduced-calorie diet and increased physical activity.